Nobody has anything nice to say about NICE - so, being a contrarian, I will!  As you may know, NICE (National Institute for Clinical Excellence) determines the drugs that should be made available on the National Health Service based upon their effectiveness and price.  Invariably it makes decisions that upset some groups, and ...

Drug companies move in a slow, slow way their profits to protect.  Even when an argument enters the realm of the blindingly obvious, we continue to see prevarication, the creation of sub-sub committees, review boards, and the review of review boards. This highly successful strategy has been used on countless occasions to buy time ...